Tagged with mexico

Pharma Building on the continuous improvements of the Federal Commission for the Protection Against Sanitary Risk (Cofepris) over the last few years, its recently-appointed Federal Commissioner Julio Sánchez y Tépoz reveals his strategy to further strengthen and develop the Commission’s processes and international leadership, and foster a more transparent, technical, efficient…

Pharma Socorro España Lomelí, executive director of Mexico’s National Association of Drug Manufacturers (ANAFAM), details her strategic priorities with regards to the promotion of the industry’s export strategy, the implementation of world-class manufacturing norms, the development of biosimilars and API manufacturing, as well as recognizing the pharmaceutical sector as a strategic…

Pharma Rafael Gual, general director of CANIFARMA, the chamber that brings together multinational and local drug manufacturers, details how the organization is currently intensifying its efforts to ensure the pharmaceutical industry as a whole is officially recognized as a strategic Mexican industry by both the Ministries of Health and Economy, while…

Health Although the country is moving in the right direction with regards to universal coverage, a number of barriers to effective implementation remain. 57.3 million previously uninsured Mexicans are now enrolled in Seguro Popular Gabriel O’Shea, Seguro Popular Healthcare is one of the next items on President Peña Nieto’s busy agenda.…

Pharma Click here to read more articles and interviews from Peru, and to download the latest free pharma report on the country. 

Mexico The following charts show manufacturing costs in the Medical Devices Industry (compared to the US in 2013) and Medical Device Exports from Mexico (in USD millions). For more data on the Mexican market, please download our latest 2015 free report here.

Mexico The below chart shows the average number of days taken to grant registration for innovative drugs. The previous number of days for Mexico (360) has been greatly reduced to 60 as of 2014. For more data on the Mexican market, please download our latest 2015 free report here.

Mexico The chart below shows the main investors into pharmaceuticals in Mexico and the main export destinations for Mexican pharmaceutical products. It also shows the production value, compound annual growth, and number of economic units in the Mexican pharmaceutical industry, as well as the number of jobs it creates and overall FDI. For more data on the Mexican…

Mexico This graph shows the growth of the Mexican market between 2009 to 2013, in both units and volume, and broken down by type. For more data on the Mexican market, please download our latest 2015 free report here

medical devices Philips aims at becoming the leading provider of solutions across the full ‘continuum of care’. The general manager of the healthcare division in Mexico explains how the company has made customer service, education, software and integrated solutions the strategic pillars to find innovative ways to deliver healthcare. What are the…

generics At Valeant each region has a unique mix of prescription brands, branded generics and OTC products. The general manager for Mexico, Central America, the Caribbean and the Andean region discusses the company’s objectives for Spanish speaking Latin America and how it plans to leverage the recently acquired Bausch+Lomb business to…

Mexico At Leo Pharma it’s not just about skin conditions. It’s about the people living with them. The recently appointed senior director for Latin America discusses the plans of the company for the region and how, in collaboration with dermatologists, it aims at reaching out to an increasing number of patients.…